CD4 and neoplasm: E2F1 knockdown severely reduced these alterations in gene expression in both cell types to 1,462 (CD4+) and 1,708 (SK-Mel-47 E2F1-KD) DEGs, respectively (Figure 3E), underlining the regulatory role of E2F1 in the crosstalk between tumor and immune cells.